Skip to main content

2014 | OriginalPaper | Buchkapitel

21. A Mathematical Model for Growing Metastases on Oncologists’s Service

verfasst von : D. Barbolosi, A. Benabdallah, S. Benzekry, J. Ciccolini, C. Faivre, F. Hubert, F. Verga, B. You

Erschienen in: Computational Surgery and Dual Training

Verlag: Springer New York

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

The dual classification of cancer as localized or metastatic disease is one of the key points in the elaboration of the best therapy for each patient. Nevertheless, many studies reveal that part of these localized diseases is already metastatic. The presence of undetectable or micro-metastases explains the necessity of adjuvant chemotherapies after resection of the primary tumor even for some T1N0M0 cancer. There is probably a continuum between these two stages.We expose here how a mathematical model of growing metastases could reflect this continuum of the disease and how such a model could help the oncologists in the choice of the treatment. This phenomenological model is based on a structured transport equations with nonlocal boundary condition describing the evolution of the density of metastasis. Thanks to this model, we forge a new numerical index, that we call Metastatic Index, able to reveal either the micro-metastatic state of the patient, or the visible metastatic one. Numerical illustrations show how this new index can be used.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Literatur
1.
Zurück zum Zitat Barbolosi D, Benabdallah A, Hubert F, Verga F (2009) Mathematical and numerical analysis for a model of growing metastatic tumors. Math Biosci 218:1–14MathSciNetCrossRefMATH Barbolosi D, Benabdallah A, Hubert F, Verga F (2009) Mathematical and numerical analysis for a model of growing metastatic tumors. Math Biosci 218:1–14MathSciNetCrossRefMATH
2.
Zurück zum Zitat Benzekry S (2011) Mathematical analysis of a two-dimensional population model of metastatic growth including angiogenesis. J Evol Equat 11(1):187–213CrossRefMATH Benzekry S (2011) Mathematical analysis of a two-dimensional population model of metastatic growth including angiogenesis. J Evol Equat 11(1):187–213CrossRefMATH
3.
Zurück zum Zitat Benzekry S (2011) Mathematical and numerical analysis of the anti-angiogenic therapy in metastatic cancers. Esaim Math Model Numer Anal 46(2):207–237MathSciNetCrossRef Benzekry S (2011) Mathematical and numerical analysis of the anti-angiogenic therapy in metastatic cancers. Esaim Math Model Numer Anal 46(2):207–237MathSciNetCrossRef
4.
Zurück zum Zitat Elias D (2006) Rationnel de la chirurgie oncologique au sein du traitement multimodal des cancers. Bull Cancer 93:775–781 Elias D (2006) Rationnel de la chirurgie oncologique au sein du traitement multimodal des cancers. Bull Cancer 93:775–781
5.
Zurück zum Zitat Hahnfeldt P, Panigraphy D, Folkman J, Hlatky L (1999) Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment, response and postvascular dormancy. Cancer Res 59:4770–4775 Hahnfeldt P, Panigraphy D, Folkman J, Hlatky L (1999) Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment, response and postvascular dormancy. Cancer Res 59:4770–4775
6.
Zurück zum Zitat Iwata K, Kawasaki K, Shigesada N (2000) A dynamical model for the growth and size distribution of multiple metastatic tumors. J Theor Biol 203:177–186CrossRef Iwata K, Kawasaki K, Shigesada N (2000) A dynamical model for the growth and size distribution of multiple metastatic tumors. J Theor Biol 203:177–186CrossRef
7.
Zurück zum Zitat Koscielny S, Tubiana M, Le MG et al (1984) Breast cancer. Relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 49:709–715CrossRef Koscielny S, Tubiana M, Le MG et al (1984) Breast cancer. Relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 49:709–715CrossRef
8.
Zurück zum Zitat Meille C (2009) Modélisation du risque des toxicités induites par des substances thérapeutiques. Ph.D. thesis, Université de la Méditerranée, France, 21 March Meille C (2009) Modélisation du risque des toxicités induites par des substances thérapeutiques. Ph.D. thesis, Université de la Méditerranée, France, 21 March
9.
Zurück zum Zitat Meille C, Iliadis A, Barbolosi D et al (2008) An interface model for dosage adjustment connects hematotoxicity to pharmacokinetics. J Pharmacokin Pharmacodyn 35:619–633CrossRef Meille C, Iliadis A, Barbolosi D et al (2008) An interface model for dosage adjustment connects hematotoxicity to pharmacokinetics. J Pharmacokin Pharmacodyn 35:619–633CrossRef
10.
Zurück zum Zitat Peeters C, phal JR, de Geus LF, Wetphal JR et al (2005) Decrease in circulating anti-angiogenic factors after removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastases. Surgery 137:246–249 Peeters C, phal JR, de Geus LF, Wetphal JR et al (2005) Decrease in circulating anti-angiogenic factors after removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastases. Surgery 137:246–249
11.
Zurück zum Zitat Verga F (2010) Modélisation mathématique du processus métastatique. Ph.D. thesis, Université de Provence, France, 23 November Verga F (2010) Modélisation mathématique du processus métastatique. Ph.D. thesis, Université de Provence, France, 23 November
12.
Zurück zum Zitat Verga F, You B, Benabdallah A, Hubert F, Faivre C, Mercier C, Ciccolini J, Barbolosi D (2011) Modélisation du risque d’évolution métastatique chez les patients supposés avoir une maladie localisée. Oncologie 13(8):528–533CrossRef Verga F, You B, Benabdallah A, Hubert F, Faivre C, Mercier C, Ciccolini J, Barbolosi D (2011) Modélisation du risque d’évolution métastatique chez les patients supposés avoir une maladie localisée. Oncologie 13(8):528–533CrossRef
13.
Zurück zum Zitat Viens P, Roché H, Kerbrat P et al (2001) Epirubicin-docetaxel combination in first line chemotherapy for patients with metastatic breast cancer. J Clin Oncol 24:328–335CrossRef Viens P, Roché H, Kerbrat P et al (2001) Epirubicin-docetaxel combination in first line chemotherapy for patients with metastatic breast cancer. J Clin Oncol 24:328–335CrossRef
14.
Zurück zum Zitat You B (2009) Inhibiteurs de tyrosine kinase et chimiothrapie: et si ctait seulement une question de scheduling? France Cancer, 19 janvier, 440 You B (2009) Inhibiteurs de tyrosine kinase et chimiothrapie: et si ctait seulement une question de scheduling? France Cancer, 19 janvier, 440
15.
Zurück zum Zitat You B, Meille C, Barbolosi D, Tranchand B, Guitton J, Rioufol C, Iliadis A, Freyer G (2007). A mechanistic model predicting hematopoiesis and tumor growth to optimize docetaxel + epirubicin (ET) administration in metastatic breast cancer (MBC): phase I trial. J Clin Oncol 25:13013 You B, Meille C, Barbolosi D, Tranchand B, Guitton J, Rioufol C, Iliadis A, Freyer G (2007). A mechanistic model predicting hematopoiesis and tumor growth to optimize docetaxel + epirubicin (ET) administration in metastatic breast cancer (MBC): phase I trial. J Clin Oncol 25:13013
Metadaten
Titel
A Mathematical Model for Growing Metastases on Oncologists’s Service
verfasst von
D. Barbolosi
A. Benabdallah
S. Benzekry
J. Ciccolini
C. Faivre
F. Hubert
F. Verga
B. You
Copyright-Jahr
2014
Verlag
Springer New York
DOI
https://doi.org/10.1007/978-1-4614-8648-0_21

Neuer Inhalt